Poly(ADP-ribose) Polymerase-1 Inhibitor 3-Aminobenzamide Enhances Apoptosis Induction by Platinum Complexes in Cisplatin-Resistant Tumor Cells
Babul Bezbaruah
Medicinal Chemistry, 2006
View PDFchevron_right
Novel platinum(IV) complexes induce rapid tumor cell deathin vitro
Vladimir Trajkovic
International Journal of Cancer, 2005
View PDFchevron_right
Inhibition of Cell Growth, Induction of Apoptosis and Mechanism of Action of the Novel Platinum Compound cis-Diaminechloro-[2-(Diethylamino) Ethyl 4-Amino-Benzoate, N 4 ]-Chloride Platinum (II) Monohydrochloride Monohydrate
Maurizio Viale
Investigational New Drugs, 2000
View PDFchevron_right
Specific Proteolytic Cleavage of Poly(ADP-ribose) Polymerase: An Early Marker of Chemotherapy-induced Apoptosis1
Serge Desnoyers
View PDFchevron_right
Molecular Aspects of Antitumor Effects of a New Platinum(IV) Drug
Giovanni Natile
Molecular Pharmacology, 2006
View PDFchevron_right
Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies
Nicola Curtin
Clinical cancer research : an official journal of the American Association for Cancer Research, 2003
View PDFchevron_right
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
Miguel Fuertes
Recent Patents on Anti-Cancer Drug Discovery, 2006
View PDFchevron_right
Macromolecular Antiproliferative Agents Featuring Dicarboxylato-Chelated Platinum
Constance Van Rensburg
Journal of Inorganic and Organometallic Polymers and Materials, 2007
View PDFchevron_right
Structural and mechanistic aspects of platinum anticancer agents
Anvarhusein Isab
Transition Metal Chemistry, 2006
View PDFchevron_right
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors
Chiara Gabbiani
Dalton Transactions, 2011
View PDFchevron_right
Molecular Mechanisms and Immunomodulatory Effects of Platinum Analogs on Some Genes and as Anticancer Drugs: Review Article
Inam Arif
2020
View PDFchevron_right
Antitumor and Cellular Pharmacological Properties of a Novel Platinum(IV) Complex:trans-[PtCl2(OH)2(Dimethylamine) (Isopropylamine)]
Miguel Fuertes
Molecular Pharmacology, 2003
View PDFchevron_right
Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064
Nicola Curtin
British journal of cancer, 1998
View PDFchevron_right
Antitumor and Cellular Pharmacological Properties of a Novel Platinum(IV) Complex:trans-[PtCl2(OH)2(Dimethylamine) (Isopropylamine)]
Miguel Fuertes
Molecular Pharmacology, 2003
View PDFchevron_right
Peptide Targeting of Platinum Anti-Cancer Drugs
Sita Aggarwal
Bioconjugate Chemistry, 2009
View PDFchevron_right
In Vitro Biochemical and Pharmacological Evaluation of a Novel Cytotoxic Dinuclear Platinum(II) Complex with 3-Amino-5-methyl-5-phenylhydantoin
Georgi Momekov, Darvin Sl. Ivanov, Spiro Konstantinov, Adriana Bakalova
Annals of the New York Academy of Sciences, 2009
View PDFchevron_right
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton
Vojtěch Novohradský
Journal of Medicinal Chemistry, 2019
View PDFchevron_right
2-(4-(tetrahydro-2 H -pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): A Novel Platinum Compound that Overcomes Cisplatin Resistance and Induces Apoptosis by Mechanisms Different from that of Cisplatin
H. Schmoll
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Synthesis of a New Polynuclear Platinum (II) Complex and Its Prodrug Forms. Evaluation of Their Cytotoxic Properties
Neli Koseva
2013
View PDFchevron_right
A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin
oscar fra mendoza
Metallomics, 2013
View PDFchevron_right
Current status of the development of trans-platinum antitumor drugs
Miguel Fuertes
Critical Reviews in Oncology/Hematology, 2000
View PDFchevron_right